Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/12/2013 | CA2443532C Measurement of microbiological activity in an opaque medium |
11/12/2013 | CA2407872C Receptor-based interaction trap |
11/07/2013 | WO2013166497A1 Method and device for preserving and imaging specimens while retaining information on the spatial orientation of specimens with respect to reference objects |
11/07/2013 | WO2013166488A1 Methods for generating the inner ear and other cranial placode-derived tissues using pluripotent stem cells |
11/07/2013 | WO2013166480A1 Detectors of serum biomarkers for predicting ovarian cancer recurrence |
11/07/2013 | WO2013166460A1 Antibiotic susceptibility testing using probes for preribosomal rna |
11/07/2013 | WO2013166431A1 Lipids that increase insulin sensitivity and methods of using the same |
11/07/2013 | WO2013166427A1 Hsf1 and hsf1 cancer signature set genes and uses relating thereto |
11/07/2013 | WO2013166373A1 Gene expression signature for il-6/stat3 signaling pathway and use thereof |
11/07/2013 | WO2013166366A1 Cul4b as predictive biomarker for cancer treatment |
11/07/2013 | WO2013166364A1 G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker |
11/07/2013 | WO2013166363A2 Methods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia |
11/07/2013 | WO2013166338A2 Cell capture system and use thereof |
11/07/2013 | WO2013166337A1 Method of detecting viable cells in a cell sample |
11/07/2013 | WO2013166336A1 Viability staining method |
11/07/2013 | WO2013166290A1 P21 biomarker assay |
11/07/2013 | WO2013166259A1 Nanoscale sensors for intracellular and other applications |
11/07/2013 | WO2013166234A1 Modified prokaryotic ubiquitin-like protein and methods of use thereof |
11/07/2013 | WO2013166220A1 Transient flow assay |
11/07/2013 | WO2013166186A1 Method for determining complete response to anticancer theraphy |
11/07/2013 | WO2013166170A1 Systems and methods for separating component materials of a suspension using immunomagnetic separation |
11/07/2013 | WO2013166169A1 Apparatus and methods for microbiological analysis |
11/07/2013 | WO2013166160A1 Systems and methods for non-fasting ldl cholesterol assays |
11/07/2013 | WO2013166153A2 Methods and compositions for cancer diagnosis |
11/07/2013 | WO2013166127A1 Ear odor sensor |
11/07/2013 | WO2013166118A2 Methods related to cancer treatment |
11/07/2013 | WO2013166106A1 Sample introduction system |
11/07/2013 | WO2013166075A1 Cobalamin acquisition protein and use thereof |
11/07/2013 | WO2013166053A2 Homogenous and fully glycosylated human erythropoietin |
11/07/2013 | WO2013166030A2 Detecting complement activation |
11/07/2013 | WO2013165969A2 Methods and kits for diagnosing heparin-induced thrombocytopenia |
11/07/2013 | WO2013165887A1 Method and apparatus for selecting wavelengths for optimal measurement of a property of a molecular analyte |
11/07/2013 | WO2013165870A1 Methods and compositions for extraction and storage of nucleic acids |
11/07/2013 | WO2013165844A1 Improved analyte measurement technique and system |
11/07/2013 | WO2013165632A1 Method for assessing an alpha particle emission potential of a metallic material |
11/07/2013 | WO2013165625A2 Explosives detection polymer comprising functionalized polyamine polymers and methods of using the same |
11/07/2013 | WO2013165615A2 Methods, systems, and devices for detecting and identifying microorganisms in microbiological culture samples |
11/07/2013 | WO2013165591A1 β-GLUCAN IMMUNOTHERAPEUTIC METHODS |
11/07/2013 | WO2013165555A1 Quantitative interpretation of cell index profiles |
11/07/2013 | WO2013165420A1 Whole blood analytic device and method therefor |
11/07/2013 | WO2013165392A1 Detectably-labeled carbon fiber |
11/07/2013 | WO2013165243A1 Closing element for closing a container for samples for analysis |
11/07/2013 | WO2013164836A1 A sensor composition for acetone detection in breath |
11/07/2013 | WO2013164823A1 Methods and systems of evaluating a risk of a gastrointestinal cancer |
11/07/2013 | WO2013164788A2 Method |
11/07/2013 | WO2013164787A1 Assay methods for diagnosing and monitoring cancer |
11/07/2013 | WO2013164763A2 A biological complex specific for alzheimer's disease detection in vitro and use thereof |
11/07/2013 | WO2013164676A1 Method to analyze the cluster formation process in a biological fluid and corresponding analysis apparatus |
11/07/2013 | WO2013164632A1 Pulsed signal testing of biological fluid |
11/07/2013 | WO2013164629A1 Apparatus and method for testing medicaments |
11/07/2013 | WO2013164611A1 An electrode and use thereof |
11/07/2013 | WO2013164476A1 Multiplex immuno screening assay |
11/07/2013 | WO2013164468A1 Fluid analysis |
11/07/2013 | WO2013164440A1 Methods related to treatment of inflammatory diseases and disorders |
11/07/2013 | WO2013164303A1 Multiphase meter |
11/07/2013 | WO2013163681A1 Fluorescent proteins and uses thereof |
11/07/2013 | WO2013138702A3 Methods for predicting gastrointestinal immune - related adverse events (gi-irae) in patients treated with co - stimulatory pathway modulators |
11/07/2013 | WO2013136334A3 Means and methods for diagnostics and therapeutics of diseases |
11/07/2013 | WO2013135245A9 High throughput screening of glycosyl hydrolase enzymes |
11/07/2013 | WO2013132088A4 A method for predicting the risk of getting a cardiovascular event in a female subject |
11/07/2013 | WO2013116333A3 Thermal contrast assay and reader |
11/07/2013 | WO2013115885A3 Synthesizing functionalized dendrimers within biological settings |
11/07/2013 | WO2013114304A3 Composition and sensor for detecting occult blood |
11/07/2013 | WO2013112836A3 Diagnostic and prognostic biomarkers for cancer |
11/07/2013 | WO2013112677A3 Multinotch isolation for ms3 mass analysis |
11/07/2013 | WO2013106778A3 Non-equilibrium two-site assays for linear, ultrasensitive analyte detection |
11/07/2013 | WO2013095137A3 Methods, means and kits for detecting scarce analytes |
11/07/2013 | WO2013093115A3 Marker sequences for breast cancer and the use thereof |
11/07/2013 | WO2013092951A3 Standard for quantifying pathogenic aggregates from proteins produced naturally in the body |
11/07/2013 | WO2013079981A3 Biomarker-based methods and biochips for aiding the diagnosis of stroke |
11/07/2013 | WO2013017430A3 System and method for tailoring food or beverage products to consumer requirements |
11/07/2013 | WO2012139122A8 Detection of nucleic acids using unmodified gold nanoparticles |
11/07/2013 | WO2003033664A9 Bone anti-resorptive compounds |
11/07/2013 | WO2002101075A9 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
11/07/2013 | WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
11/07/2013 | WO2002079443A3 Transgenic mice containing 5-ht5b serotonin receptor gene disruptions |
11/07/2013 | US20130298263 Nucleic acid construct for expression of oxidative stress indicator and use thereof |
11/07/2013 | US20130297327 Health monitoring system |
11/07/2013 | US20130297222 Method and apparatus for analyte measurements using calibration sets |
11/07/2013 | US20130296676 Biosensor Membranes |
11/07/2013 | US20130296574 Preparation of sensors on oligo- or poly (ethylene glycol) films on silicon surfaces |
11/07/2013 | US20130296397 Early marker of proteinuria in patients treated with an anti-vegf treatment |
11/07/2013 | US20130296281 Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels |
11/07/2013 | US20130296240 Pneumonia biomarkers |
11/07/2013 | US20130296188 Targeting metabolic enzymes in human cancer |
11/07/2013 | US20130296186 Self-encoding sensor with microspheres |
11/07/2013 | US20130296185 Tape stripping methods for analysis of skin disease and pathological skin state |
11/07/2013 | US20130296184 Novel Method for Diagnosing Lyme Disease Using a Cellular Immunological Test |
11/07/2013 | US20130296179 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
11/07/2013 | US20130296175 Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment |
11/07/2013 | US20130295692 Means and methods for predicting diabetes |
11/07/2013 | US20130295691 Method of Attaching a Ligand to a Test Strip |
11/07/2013 | US20130295689 Method for detection of basic peptide and reagent for detection of basic peptide |
11/07/2013 | US20130295686 Intercalation methods and devices |
11/07/2013 | US20130295685 Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies |
11/07/2013 | US20130295681 Device, system and method for measuring homeostasis, vitality, energy and stress in an individual or substance |
11/07/2013 | US20130295680 Gas sensor incorporating a porous framework |
11/07/2013 | US20130295677 Method and apparatus for determining formation fluid composition |
11/07/2013 | US20130295664 Microbial air sampler |
11/07/2013 | US20130295657 Device and Method for the Detection of Particles |